News

Medical Polymers Pave the Way for More Efficient Medical Device Tech

A state panel has awarded nearly $300,000 to a nonprofit group that will coordinate efforts to enhance the technology ecosystem in the Roanoke, New River Valley and Lynchburg regions.

The grant from the GO Virginia state board comes with $150,000 in matching funds from local supporters.

The board also approved $100,000 for a study of the best future use of the Central Virginia Training Center, a state institution in Madison Heights that is scheduled to close next year, according to a news release from GO Virginia’s Region 2, which represents the Roanoke, New River, Lynchburg and Alleghany Highland areas.

GO Virginia is a statewide initiative designed to encourage Virginia’s economic growth through the creation of high-wage jobs. Nine regional councils vet applications and recommend projects in their respective areas.

In October, the Region 2 council backed $299,995 in state funding for the Valleys Innovation Council, a Blacksburg-based nonprofit formed last year, to create a Regional Entrepreneurship Initiative to facilitate coalitions and stakeholder engagement.

The initiative will convene a steering group to oversee efforts in three sub-regions: the New River Valley, the Roanoke Valley-Alleghany Highlands, and the Lynchburg area.

A pipeline of projects will be developed, with one measurement of progress being the number of grants from GO Virginia and other sources to support business startups and other innovation and entrepreneurship efforts in the region’s industry clusters.

Fields include advanced manufacturing, life science and health care, and emerging technologies such as autonomous systems, blockchain and cybersecurity.

While the area tops state and national averages for academic research expenditures, that has failed to translate into economic growth at the rate desired by organizers. Region 2 has a 5% rate of new business formation, compared to 7% for Virginia and 8% for the United States.

Aiming to reverse that trend, the Valleys Innovation Council has outlined a number of steps to be implemented on a quarterly basis through the end of 2021.

Recent News

02/24/2026

Jeeva Clinical Trials Calls on Global Life Sciences Leaders to Modernize Infrastructure for AI-Driven Drug Development

Jeeva Clinical Trials today amplified its call to action for the global pharmaceutical and clinical research ecosystem: Artificial Intelligence will not transform drug development unless organizations modernize the IT infrastructure beneath it. The message — first articulated in a recent thought leadership article by Founder and CEO Harsha K. Rajasimha — has gained strong traction

02/24/2026

Liquet™ Medical Receives Second FDA 510(k) Clearance for Versus™ Catheter

Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today announced it has received a second 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new configuration of the Versus™ Catheter. The latest clearance expands the company’s proprietary platform and opens access to a broader

02/17/2026

Serpin Pharma, Inc. Announces Approval to Initiate EASE‑AKI Phase II Clinical Trial in Germany

Serpin Pharma, Inc., a clinical‑stage biopharmaceutical company developing first‑in‑class LRP1‑agonist therapeutics, today announced that its Phase II clinical trial, EASE-AKI, has received unconditional approval to begin enrolling patients in Germany. The study will evaluate SP16, a powerful yet well-tolerated anti-inflammatory peptide, designed to protect the kidneys of patients with chronic kidney disease who are undergoing